NO20080163L - Aminopyrimidiner som kinasemodulatorer - Google Patents
Aminopyrimidiner som kinasemodulatorerInfo
- Publication number
- NO20080163L NO20080163L NO20080163A NO20080163A NO20080163L NO 20080163 L NO20080163 L NO 20080163L NO 20080163 A NO20080163 A NO 20080163A NO 20080163 A NO20080163 A NO 20080163A NO 20080163 L NO20080163 L NO 20080163L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- trkb
- flt3
- kit
- aminopyrimidines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
Foreliggende oppfinnelse angår aminopyrimidin forbindelser med Formel I: hvori R3, B, Z, Q, p, q og R1 er som definert heri, anvendelsen av slike forbindelser som protein tyrosin kinase modulatorer, særlig inhibitorer av FLT3 og/eller c-kit og/eller TrkB, anvendelsen av slike forbindelser for å redusere eller inhibere kinase aktivitet av FLT3 og/eller c-kit og/eller TrkB i en celle eller hos et subjekt, og anvendelsen av slike forbindelser for å hindre eller behandle en celleproliferativ forstyrrelse og/eller forstyrrelser relatert til FLT3 og/eller c-kit og/eller TrkB hos et subjekt. Foreliggende oppfinnelse angår videre fannasøytiske sammensetninger som innbefatter forbindelsene i følge oppfinnelsen og fremgangsmåter for behandling av tilstander slike som kreft og andre celle proliferative forstyrrelser.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68971705P | 2005-06-10 | 2005-06-10 | |
US75108405P | 2005-12-16 | 2005-12-16 | |
PCT/US2006/022165 WO2006135644A1 (en) | 2005-06-10 | 2006-06-07 | Aminopyrimidines as kinase modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080163L true NO20080163L (no) | 2008-03-07 |
Family
ID=36929309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080163A NO20080163L (no) | 2005-06-10 | 2008-01-09 | Aminopyrimidiner som kinasemodulatorer |
Country Status (17)
Country | Link |
---|---|
US (1) | US20060281764A1 (no) |
EP (1) | EP1896029A1 (no) |
JP (1) | JP2008543760A (no) |
KR (1) | KR20080028911A (no) |
AR (1) | AR053895A1 (no) |
AU (1) | AU2006258054A1 (no) |
BR (1) | BRPI0611963A2 (no) |
CA (1) | CA2611470A1 (no) |
EA (1) | EA200800015A1 (no) |
EC (1) | ECSP077991A (no) |
GT (1) | GT200600248A (no) |
IL (1) | IL187693A0 (no) |
NI (1) | NI200700316A (no) |
NO (1) | NO20080163L (no) |
PE (1) | PE20070076A1 (no) |
TW (1) | TW200718693A (no) |
WO (1) | WO2006135644A1 (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1928862A1 (en) * | 2005-09-13 | 2008-06-11 | Palau Pharma, S.A. | 2-aminopyrimidine derivatives as modulators of the histamine h4 receptor activity |
CN101511359B (zh) | 2006-09-08 | 2012-09-05 | 霍夫曼-拉罗奇有限公司 | 苯并三唑激酶调节剂 |
JP2010504362A (ja) * | 2006-09-25 | 2010-02-12 | アレテ セラピューティクス, インコーポレイテッド | 可溶性エポキシドヒドロラーゼ阻害剤 |
US20080234332A1 (en) * | 2007-03-20 | 2008-09-25 | Xiong Cai | Raf kinase inhibitors containing a zinc binding moiety |
US20110275094A1 (en) * | 2008-11-06 | 2011-11-10 | Gunawardane Ruwanthi N | Phosphorylated fms-related tyrosine kinase 3 biomarker assay |
CN102272120B (zh) * | 2008-11-07 | 2013-12-25 | H.隆德贝克有限公司 | 生物活性酰胺 |
HUE043522T2 (hu) | 2009-09-04 | 2019-08-28 | Biogen Ma Inc | Bruton tirozinkináz inhibitorok |
AR091273A1 (es) | 2012-06-08 | 2015-01-21 | Biogen Idec Inc | Inhibidores de pirimidinil tirosina quinasa |
MX2019000884A (es) | 2016-07-21 | 2019-09-04 | Biogen Ma Inc | Formas de succinato y composiciones de inhibidores de la tirosina cinasa de bruton. |
EP3519385B1 (en) * | 2016-09-27 | 2020-11-18 | Mission Therapeutics Limited | Cyanopyrrolidine derivatives with activity as inhibitors of usp30 |
KR20190121404A (ko) * | 2017-03-16 | 2019-10-25 | 크리네틱스 파마슈티칼스, 인크. | 소마토스타틴 조절제 및 이의 용도 |
JP7365347B2 (ja) | 2018-02-12 | 2023-10-19 | クリネティックス ファーマシューティカルズ,インク. | ソマトスタチンモジュレーターおよびその使用 |
WO2020061046A1 (en) | 2018-09-18 | 2020-03-26 | Crinetics Pharmaceuticals, Inc. | Somatostatin modulators and uses thereof |
TW202115008A (zh) | 2019-08-14 | 2021-04-16 | 美商克林提克斯醫藥股份有限公司 | 非肽生長抑制素(somatostatin)5型受體激動劑及其用途 |
US11773076B2 (en) | 2021-02-17 | 2023-10-03 | Crinetics Pharmaceuticals, Inc. | Crystalline forms of a somatostatin modulator |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE253915T1 (de) * | 1999-06-30 | 2003-11-15 | Merck & Co Inc | Src-kinase hemmende verbindungen |
WO2003026666A1 (en) * | 2001-09-26 | 2003-04-03 | Bayer Pharmaceuticals Corporation | 2-phenylamino-4- (5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, as src kinase inhibitors |
-
2006
- 2006-06-06 US US11/422,362 patent/US20060281764A1/en not_active Abandoned
- 2006-06-07 WO PCT/US2006/022165 patent/WO2006135644A1/en active Application Filing
- 2006-06-07 PE PE2006000625A patent/PE20070076A1/es not_active Application Discontinuation
- 2006-06-07 EP EP06772456A patent/EP1896029A1/en not_active Withdrawn
- 2006-06-07 KR KR1020087000399A patent/KR20080028911A/ko not_active Application Discontinuation
- 2006-06-07 BR BRPI0611963-8A patent/BRPI0611963A2/pt not_active Application Discontinuation
- 2006-06-07 CA CA002611470A patent/CA2611470A1/en not_active Abandoned
- 2006-06-07 AU AU2006258054A patent/AU2006258054A1/en not_active Abandoned
- 2006-06-07 JP JP2008515885A patent/JP2008543760A/ja not_active Withdrawn
- 2006-06-07 EA EA200800015A patent/EA200800015A1/ru unknown
- 2006-06-07 NI NI200700316A patent/NI200700316A/es unknown
- 2006-06-08 GT GT200600248A patent/GT200600248A/es unknown
- 2006-06-09 AR ARP060102426A patent/AR053895A1/es not_active Application Discontinuation
- 2006-06-09 TW TW095120473A patent/TW200718693A/zh unknown
-
2007
- 2007-11-27 IL IL187693A patent/IL187693A0/en unknown
- 2007-12-10 EC EC2007007991A patent/ECSP077991A/es unknown
-
2008
- 2008-01-09 NO NO20080163A patent/NO20080163L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20080028911A (ko) | 2008-04-02 |
PE20070076A1 (es) | 2007-02-09 |
WO2006135644A1 (en) | 2006-12-21 |
IL187693A0 (en) | 2008-08-07 |
CA2611470A1 (en) | 2006-12-21 |
BRPI0611963A2 (pt) | 2010-10-13 |
TW200718693A (en) | 2007-05-16 |
NI200700316A (es) | 2009-03-03 |
AR053895A1 (es) | 2007-05-23 |
EA200800015A1 (ru) | 2008-06-30 |
GT200600248A (es) | 2007-03-14 |
ECSP077991A (es) | 2008-01-23 |
EP1896029A1 (en) | 2008-03-12 |
US20060281764A1 (en) | 2006-12-14 |
JP2008543760A (ja) | 2008-12-04 |
AU2006258054A1 (en) | 2006-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20080163L (no) | Aminopyrimidiner som kinasemodulatorer | |
NO20080168L (no) | Aminoquinolin- og aminoquinoazolinkinasemodulatorer | |
NO20080161L (no) | Aminopyrimidiner som kinasemodulatorer | |
NO20083013L (no) | Triazolopyridaziner som tyrosinkinasemodulatorer | |
NO20080174L (no) | Alkylquinolin- og alkylquinazolinkinasemodulatorer | |
NO20061194L (no) | Mitotiske kinesininbibitorer | |
NO20080162L (no) | Tienopyrimidin og tienopyrimidinderivater som FLT-3 kinaseinhibitorer | |
NO20082508L (no) | Aminopyrimidiner anvendelige som kinaseinhibitorer | |
NO20070506L (no) | Fremgangsmater og mellomprodukter nyttige for fremstilling av kondenserte heterocykliske kinase inhibitorer. | |
NO20073140L (no) | Pyrrolopyraziner og pyralopyraziner som er nyttige som inhibitorer av proteinkinaser | |
EA201000093A1 (ru) | Производные пиридазинона | |
NO20084496L (no) | Pyridyl- og pyrimidinylsubstituerte pyrrol-, tiofen- og furanderivater som kinaseinhibitorer | |
NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
ATE497496T1 (de) | 2,4-pyridimediamon-derivate als hemmer von jak- kinasen zur behandlung von autoimmunerkrankungen | |
NO20074634L (no) | Substituerte heterocykler og deres anvendelse som CHK1-, PDK1- og PAK-inhibitorer | |
NO20072747L (no) | Fremgangsmate for fremstilling av indazolforbindelser | |
EA201100966A1 (ru) | Производные пиридазинона | |
ATE557014T1 (de) | Neue substituierte indolin-2-on-derivate und ihre verwendung als p38-mitogenaktivierte kinasehemmer | |
MX2010002004A (es) | Compuestos de 5-(4-(halo-alcoxi)-fenil)-pirimidin-2-amina y composiciones con inhibidores de cinasa. | |
NO20090608L (no) | Tyrosinkinaseinhibitorer | |
EA201001648A1 (ru) | Производные пиридазинона | |
ATE484501T1 (de) | Als protein-kinase-inhibitoren nutzbare benzimidazole | |
NO20080417L (no) | Benzosykloheptapyridiner som inhibitorer av reseptortyrosinkinasen MET | |
EA201001576A1 (ru) | Тиенопиримидины | |
NO20080160L (no) | Mellomprodukter nyttige i syntesene av alkylkinolin og alkylkinazolin kinasemodulatorer og beslektede fremgangsmater for synteser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |